The odds remained significantly higher with the addition of comorbidities, albumin levels, and hemoglobin levels, and were not attenuated with the addition of HSA-level measures of health delivery quality and socioeconomic attributes, location with respect to the urban/rural continuum, or patient insurance or access to pre–kidney failure nephrologist care (Table 2). This evidence concerns the gene ALB and kidney failure.